A new analysis comparing the amount of funding invested into stem cell research clearly demonstrates declining investment in Germany. In contrast, the US, the UK, Sweden and Japan have increased their investments into the future field.
Finnish-Swedish biomaterial expert Stora Enso has appointed Annica Bresky as Executive Vice President, Consumer Board division and member of the Group Leadership Team. Bresky joins from Iggesund Paperboard AB, part of the Swedish Holmen Group, where she held the position of President and CEO.
Investors are once again flocking to back biotechs in Europe. Belgian Life Sciences fund Fund+ has raised €125m – a quarter more than initially anticipated.
Irish drug developer Icon plc has announced that, come March 2017, Steve Cutler will take over the leadership of the company. He succeeds Ciaran Murray, who will in turn transition to the role of Chairman of the Board.
Part microbe, part machine: cyborg bacteria developed at ETH Zurich could revolutionise the biotechnological production of molecules. The bacteria have been engineered to respond to light signals.
Nordic Nanovector is expanding its foothold in cancer-fighting ADCs. The Oslo-based biotech has inked a leukaemia pact with Wilex subsidiary Heidelberg Pharma.
The enhanced Taq DNA polymerase, available in standard and hot-start formats, offers a balance between performance and value.
Miquel A. Pericàs has taken over as general director of the Barcelona Institute of Science and Technology (BIST). The chemical engineer has been holding the position of director of the Institute of Chemical Research of Catalonia since 2000.
Trial transparency has been a hotly debated topic over the last months, but now, the EMA is turning words into action. The agency will allow public access to clinical trial reports, starting now.
3P Biopharmaceuticals has hired Andrew Carver as its new Senior Head of Business Development. Carver joins 3P from UK-based CDMO Fujifilm Diosynth Biotechnology.